Company: VEEAW
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001213900-25-002701
Chunk: 42

Company: VEEA INC.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 42
---
 Act of 2002 (the “Sarbanes-Oxley Act”) requires, among other things, that as a publicly traded company, Veea discloses whether our internal control over
financial reporting and disclosure controls and procedures are effective.

A material weakness is a deficiency, or combination
of deficiencies, in internal controls over financial reporting such that there is a reasonable possibility that a material misstatement
of Veea’s annual or interim financial statements will not be prevented or detected on a timely basis. While Veea continually undertakes
steps to improve Veea’s internal controls over financial reporting as Veea’s business changes, Veea may not be successful
in making the improvements and changes necessary to be able to identify and remediate control deficiencies or material weaknesses on a
timely basis. If Veea is unable to successfully remediate any current or future material weaknesses in Veea’s internal controls
over financial reporting, the accuracy and timing of Veea’s financial reporting may be adversely affected; Veea’s liquidity,
access to capital markets and perceptions of Veea’s creditworthiness may be adversely affected; Veea may be unable to maintain compliance
with securities laws, stock exchange listing requirements and debt instruments covenants regarding the timely filing of periodic reports;
Veea may be subject to regulatory investigations and penalties; investors may lose confidence in its financial reporting; Veea may suffer
defaults under Veea’s debt instruments; and Veea’s stock price may decline.

Risks Related to Our Intellectual Property

If Veea is unable to obtain and maintain patent protection for Veea’s products and other proprietary technologies Veea develops, or if the scope of the patent protection obtained is not sufficiently broad, Veea’s competitors could develop and commercialize products and technology similar or identical to Veea’s, and Veea’s ability to successfully commercialize Veea’s products and other proprietary technologies Veea may develop may be adversely affected.

Veea’s success depends in large part on
Veea’s ability to obtain and maintain patent protection in the U.S. and other countries with respect to Veea’s products and
other proprietary technologies Veea may develop. In order to protect Veea’s proprietary position, Veea has filed and intends to
file additional patent applications in the U.S. and abroad relating to Veea’s products and other proprietary technologies Veea may
develop; however, there can be no assurance that any such patent applications will issue as granted patents or that a granted patent will
provide sufficient coverage for Veea’s products